1/3

FIEO Registered Export Ready

Gliclazide Modified-releaseTablets 60 mg

Name: Gliclazide Modified-releaseTablets 60 mg
Brand: indiglobal exports
SKU: 8520215
Availability: InStoreOnly

Sold by indiglobal exports · Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for indiglobal exports.

Compliance & Certifications

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Panchkula Dispatch on request FIEO member

indiglobal exports

Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

We are a distinguished merchant trading and export company, specializing in the international supply of premium-quality products across various sectors. Our portfolio includes pharmaceuticals, marketed under a neutral code, as well as millets, mango pulp, compounded animal and livestock feed, and orthopaedic appliances. We take great pride in our meticulous product selection and procurement processes, consistently adhering to the highest standards of quality assurance to ensure the delivery of superior goods to our clients.

Registered address: Chandigarh, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Medical Equipment & Supplies.

View profile All products

Established

2024

Employees

1–10

GST

06EOGPS3248L1ZF

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Apr 2024

Turnover

2500001 - 10000000.

Incorporation Type

On request

Verified Seller IEC Certificate GST Certificate UDYAM Registration Certificate

Product details

What are the specifications of this product?

Overview

Gliclazide Modified-release Tablets 60 mg is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations. Features: Used in the management of diabetes conditions Precise dosage form and active pharmaceutical ingredients Suitable for international pharmaceutical markets Manufactured in GMP-compliant facilities Reliable therapeutic performance Attributes: Category: Diabetes Formulation: Tablet Packaging: Export-grade blister or strip packs Shelf Life: As per regulatory standards Manufacturer: IndiGlobal Exports

Product Description

Product Overview

Gliclazide Modified-release Tablets 60 mg is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.

Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.

Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.

Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.

Description provided by indiglobal exports.

Specifications

Active Ingredient	Gliclazide
Strength per Tablet	60 mg
Dosage Form	Modified-release Tablet
Therapeutic Class	Antidiabetic agent
Packaging Type	Blister or strip packs
Compliance Standards	WHO-GMP, IP/USP quality standards
Shelf Life	As per regulatory guidelines, typically 24 months
Intended Markets	International export including regulated and semi-regulated pharmaceutical markets
Manufacturer	IndiGlobal Exports

Use cases

Category	Pharmaceuticals > Diabetes Care > Antidiabetic Medications > Oral Antidiabetic Drugs
Primary application	Wholesale, distribution, and international sourcing
Brand	indiglobal exports
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Gliclazide Modified-releaseTablets 60 mg. Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the advantage of the modified-release formulation of Gliclazide 60 mg tablets?

A: The modified-release formulation ensures a controlled and sustained release of Gliclazide over time, which helps in maintaining stable blood glucose levels and reduces the frequency of dosing, thereby enhancing patient adherence.

Q: Are these Gliclazide tablets suitable for export to international regulated markets?

A: Yes, these tablets are manufactured under WHO-GMP compliance and meet IP/USP pharmacopoeial standards, making them suitable for export to both regulated and semi-regulated international pharmaceutical markets.

Q: What packaging options are available for these Gliclazide Modified-release tablets?

A: The product is typically available in export-quality blister or strip packs designed for bulk supply to hospitals, pharmacies, and institutional clients.

Q: Who is the manufacturer of these Gliclazide Modified-release Tablets 60 mg?

A: IndiGlobal Exports is the reputable manufacturer producing these tablets in GMP-compliant facilities with stringent quality control.

Q: What is the shelf life of the Gliclazide Modified-release Tablets 60 mg?

A: The shelf life is as per international regulatory standards, commonly around 24 months, ensuring product stability and efficacy throughout its usage period.

Question not answered? Ask sellers directly — typical response within 4 hours.